The use of phosphate‐affinity SDS‐PAGE to measure the cardiac troponin I phosphorylation site distribution in human heart muscle
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
We have used phosphate affinity SDS‐PAGE to separate the phosphorylated species of cardiac troponin I (cTnI). To test the method we phosphorylated pure cTnI with protein kinase A catalytic subunit and observed up to six bands corresponding to 0, 1P, 2P, 3P, 4P and 5P phospho‐species. We examined the phospho‐species of cTnI in human heart myofibrillar extracts by phosphate affinity SDS‐PAGE and Western blotting with a non‐specific troponin I (TnI) antibody. In donor heart samples the bis‐phosphorylated species of cTnI predominated and no more highly phosphorylated species were not detectable (0P was 10.3±1.9%, 1P, 17.5±3.5%, 2P, 72.2±4.7%, 11 samples). Total phosphorylation was 1.62±0.06 molsPi/mol TnI. In myofibrils from end‐stage failing hearts, the unphosphorylated cTnI species predominated (0P was 78.5±1.8%, 1P, 17.5±1.9%, 2P, 4.0±0.7%, total phosphorylation 0.26±0.02 molsPi/mol TnI, five samples). Muscle from patients with hypertrophic obstructive cardiomyopathy was also largely unphosphorylated (0P was 76.6±3.1%, 1P, 17.5±2.7%, 2P, 5.9±0.8%, total phosphorylation 0.29±0.04 molsPi/mol TnI, 19 samples). Using a range of phospho‐specific antibodies we demonstrated that 3/4 of the bis‐phosphorylated band of donor heart cTnI is phosphorylated at Ser22 and Ser23 in approximately equal amounts and that phosphorylation of Ser43 and Thr142 was not detected.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The decrease in cTnI phosphorylation at Ser22/23 observed in this study (Figs. 2 A, C, and E) is consistent with previous reports which investigated HCM (59, 61, 62).”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [59]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961 · cited 2×
“Discontinuous SDS-PAGE gels (Laemmli) [23] were handcast and run using the Mini-PROTEAN system (Bio-Rad).”
MethodLounging in a lysosome: the intracellular lifestyle of Coxiella burnetii
Voth, D. E., & Heinzen, R. A. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00901.x · Cited by 11,767
Phosphate-binding Tag, a New Tool to Visualize Phosphorylated Proteins
Kinoshita, E., Kinoshita-Kikuta, E., Takiyama, K., & Koike, T. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t500024-mcp200 · Cited by 1,101 · cited 4×
“Gel compositions are as follows: stacking gel: 4% acrylamide (29:1 acrylamide:bis-acrylamide), resolving gel: 10% acrylamide (29:1 acrylamide:bis-acrylamide), 50mM Mn-Phos-tag TM - Acrylamide (NARD Institute, Hyogo, Japan) [18, 19].”
BackgroundInfluentialBowling, N., Walsh, R. A., Song, G., Estridge, T., Sandusky, G. E., Fouts, R. L., Mintze, K., Pickard, T., Roden, R., Bristow, M. R., et al. (1999) · Circulation · doi:10.1161/01.cir.99.3.384 · Cited by 457
In vivo regulation of Yorkie phosphorylation and localization
Oh, H., & Irvine, K. D. (2008) · Development · doi:10.1242/dev.015255 · Cited by 404 · cited 1×
“The method has been validated using pure proteins and has been applied to specific phosphoproteins in complex mixtures using Western blotting with specific antibodies [20–22].”
MethodRegulation of cardiac contractile function by troponin I phosphorylation
LAYLAND, J., SOLARO, R., & SHAH, A. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.022 · Cited by 385 · cited 4×
“Serines 22 and 23 (23 and 24 in the translated human cDNA sequence) are well established as the main sites in hcTnI phosphorylated by PKA [2, 32, 33].”
BackgroundInfluentialTroponin and Tropomyosin: Proteins That Switch on and Tune in the Activity of Cardiac Myofilaments
Solaro, R. J., & Rarick, H. M. (1998) · Circulation Research · doi:10.1161/01.res.83.5.471 · Cited by 359 · cited 1×
“Serines 22 and 23 (23 and 24 in the translated human cDNA sequence) are well established as the main sites in hcTnI phosphorylated by PKA [2, 32, 33].”
BackgroundVANDERVELDEN, J., PAPP, Z., ZAREMBA, R., BOONTJE, N., DEJONG, J., OWEN, V, BURTON, P., GOLDMANN, P., JAQUET, K., & STIENEN, G. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00606-5 · Cited by 301 · cited 5×
“Since we and others have observed that cTnT is constitutively phosphorylated [4, 5, 17] we dephosphorylated myofibrils with PP1a and PP2a (Fig.”
BackgroundMethodInfluentialIncreased Expression of Cardiac Phosphatases in Patients with End-stage Heart Failure
Neumann, J., Eschenhagen, T., Jones, L. R., Linck, B., Schmitz, W., Scholz, H., & Zimmermann, N. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0271 · Cited by 263 · cited 1×
“On the other hand, non-specific reduction in phosphorylation is compatible with reports of increased phosphatase activity in failing heart, which may itself be a consequence of enhanced PKC activity [4, 41–44].”
BackgroundTroponin I Phosphorylation in the Normal and Failing Adult Human Heart
Bodor, G. S., Oakeley, A. E., Allen, P. D., Crimmins, D. L., Ladenson, J. H., & Anderson, P. A. W. (1997) · Circulation · doi:10.1161/01.cir.96.5.1495 · Cited by 225 · cited 1×
“02 molsPi/mol hcTnI is similar to our previous measurements using the Pro-Q Diamond gel staining technique; indeed most studies have found phosphorylation levels to be very low in end-stage heart failure [4–6, 39].”
MethodSarcomeric dysfunction in heart failure
Hamdani, N., Kooij, V., van Dijk, S., Merkus, D., Paulus, W. J., Remedios, C. D., Duncker, D. J., Stienen, G. J. M., & van der Velden, J. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm079 · Cited by 181 · cited 2×
“02 molsPi/mol hcTnI is similar to our previous measurements using the Pro-Q Diamond gel staining technique; indeed most studies have found phosphorylation levels to be very low in end-stage heart failure [4–6, 39].”
BackgroundMethodMetzger, J. M., & Westfall, M. V. (2004) · Circulation Research · doi:10.1161/01.res.0000110083.17024.60 · Cited by 179 · cited 1×
“Serines 22 and 23 (23 and 24 in the translated human cDNA sequence) are well established as the main sites in hcTnI phosphorylated by PKA [2, 32, 33].”
BackgroundMesser, A. E., Jacques, A. M., & Marston, S. B. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.08.017 · Cited by 177 · cited 10×
“A high level of TnI phosphorylation has been shown in myofibrils from donor heart [4].”
BackgroundMethodResultInfluentialSelf-citationJideama, N. M., Noland, T. A., Raynor, R. L., Blobe, G. C., Fabbro, D., Kazanietz, M. G., Blumberg, P. M., Hannun, Y. A., & Kuo, J. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23277 · Cited by 170 · cited 1×
“In vitro, PKC has been shown to catalyse phosphorylation at Ser22, Ser23, Ser41, Ser43 and Thr142 whilst PAK kinase and AMP kinase phosphorylate Ser149 [2, 9, 10, 38].”
BackgroundBelin, R. J., Sumandea, M. P., Allen, E. J., Schoenfelt, K., Wang, H., Solaro, R. J., & de Tombe, P. P. (2007) · Circulation Research · doi:10.1161/circresaha.107.148288 · Cited by 157 · cited 1×
“This finding seems to contradict studies indicating increased PKC activity in heart failure, which would increase phosphorylation at the PKC sites of hcTnI [12, 13, 40].”
BackgroundBarbieri, C. M., & Stock, A. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.02.004 · Cited by 148 · cited 1×
“The method has been validated using pure proteins and has been applied to specific phosphoproteins in complex mixtures using Western blotting with specific antibodies [20–22].”
MethodLabel-free Kinase Profiling Using Phosphate Affinity Polyacrylamide Gel Electrophoresis
Kinoshita‐Kikuta, E., Aoki, Y., Kinoshita, E., & Koike, T. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t600044-mcp200 · Cited by 145
El-Armouche, A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.005 · Cited by 141 · cited 1×
“On the other hand, non-specific reduction in phosphorylation is compatible with reports of increased phosphatase activity in failing heart, which may itself be a consequence of enhanced PKC activity [4, 41–44].”
BackgroundNoland, T. A., Raynor, R. L., & Kuo, J. F. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47130-5 · Cited by 131 · cited 2×
“In vitro, PKC has been shown to catalyse phosphorylation at Ser22, Ser23, Ser41, Ser43 and Thr142 whilst PAK kinase and AMP kinase phosphorylate Ser149 [2, 9, 10, 38].”
BackgroundPi, Y., Zhang, D., Kemnitz, K. R., Wang, H., & Walker, J. W. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.045260 · Cited by 129 · cited 2×
“It has been proposed that phosphorylation at the PKC sites may be increased in heart failure although studies on human heart muscle do not support this and phosphorylation at the three PKC-specific sites has not been positively identified in any tissue sample [2, 12, 13].”
BackgroundZabrouskov, V., Ge, Y., Schwartz, J. C., & Walker, J. W. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700524-mcp200 · Cited by 125 · cited 4×
“Amino acid numbering used in this paper corresponds to the mature human cardiac sequence of 209 amino acids (lacking the N-terminal methionine of the cDNA sequence [16]).”
BackgroundMethodInfluentialMyosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle
Jacques, A. M., Copeland, O., Messer, A. E., Gallon, C. E., King, K., McKenna, W. J., Tsang, V. T., & Marston, S. B. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.05.020 · Cited by 109 · cited 1×
“These results are in accord with preliminary measurements on hcTnI using Pro-Q Diamond [8, 45] and reflect a generalised decrease in phosphorylation levels that includes TnT, myosin binding protein-C and myosin light chain-2 [46, 47], presumably associated with increased phosphatase activity [4].”
ResultSelf-citationKinoshita, E., Kinoshita‐Kikuta, E., Matsubara, M., Yamada, S., Nakamura, H., Shiro, Y., Aoki, Y., Okita, K., & Koike, T. (2008) · PROTEOMICS · doi:10.1002/pmic.200800243 · Cited by 93 · cited 1×
“The method has been validated using pure proteins and has been applied to specific phosphoproteins in complex mixtures using Western blotting with specific antibodies [20–22].”
MethodLayland, J., Cave, A. C., Warren, C. M., Grieve, D., Sparks, E., Kentish, J. C., Solaro, R. J., & Shah, A. M. (2005) · The FASEB Journal · doi:10.1096/fj.04-2519fje · Cited by 93 · cited 1×
“Ca(21)-sensitivity and increases relaxation rates in cardiac muscle, thus playing an essential lusitropic role as part of the inotropic response to adrenergic stimulation [3].”
BackgroundBuscemi, N., Foster, D. B., Neverova, I., & Eyk, J. E. V. (2002) · Circulation Research · doi:10.1161/01.res.0000035246.27856.53 · Cited by 92
Ayaz‐Güner, Ş., Zhang, J., Li, L., Walker, J. W., & Ge, Y. (2009) · Biochemistry · doi:10.1021/bi900739f · Cited by 87 · cited 2×
“phosphorylation at serines 23 and 24 [34].”
ResultTroponin phosphorylation and myofilament Ca2+-sensitivity in heart failure: Increased or decreased?
Marston, S. B., & de Tombe, P. P. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.07.004 · Cited by 78 · cited 2×
“The significance of this observation is that the widespread use of donor heart material as a source of ‘‘normal’’ control tissue has been criticised on the grounds that such tissue may be abnormally highly phosphorylated [7, 36].”
BackgroundSelf-citationA common motif of two adjacent phosphoserines in bovine, rabbit and human cardiac troponin I
Mittmann, K., Jaquet, K., & Heilmeyer, L. M. G. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81046-q · Cited by 74
Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies
Zaremba, R., Merkus, D., Hamdani, N., Lamers, J. M. J., Paulus, W. J., dos Remedios, C., Duncker, D. J., Stienen, G. J. M., & van der Velden, J. (2007) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.200600891 · Cited by 74 · cited 5×
“The Pro-Q Diamond-based calculation may be subject to errors due to the variability in sensitivity and potential non-specificity of the Pro-Q Diamond phosphoprotein stain [17, 35] as well as the need for calibration against a separately measured standard.”
BackgroundMethodInfluentialMyofilament dysfunction in cardiac disease from mice to men
Hamdani, N., de Waard, M., Messer, A. E., Boontje, N. M., Kooij, V., van Dijk, S., Versteilen, A., Lamberts, R., Merkus, D., dos Remedios, C., et al. (2008) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-008-9160-y · Cited by 71 · cited 1×
“Recent surveys show that the ‘‘normal’’ level of cTnI phosphorylation in myofibrils varies between species, being high in mouse, rabbit, cow and human and low in pig [14, 37]; using phosphate affinity SDS-PAGE we found phosphorylation in mouse myofibrils was similar to human donor heart (7675.”
ResultSelf-citationKOBAYASHI, T., Yang, X., Walker, L. A., van Breemen, R. B., & Solaro, R. J. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.10.014 · Cited by 63
Some properties of cardiac troponin T structure
Gusev, N. B., Barskaya, N. V., Verin, A. D., Duzhenkova, I. V., Khuchua, Z. A., & Zheltova, A. O. (1983) · Biochemical Journal · doi:10.1042/bj2130123 · Cited by 55
Solis, R. S., Ge, Y., & Walker, J. W. (2008) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-009-9168-y · Cited by 53 · cited 2×
“Studies using 2-DE or MS have indicated that hcTnT is phosphorylated constitutively at a single site in myofibrils or purified whole troponin [5, 17, 31] and early studies using amino acid sequencing placed the major site of phosphorylation at serine 1 [48].”
BackgroundMethodPathological defects in congenital myopathies
Sewry, C. A. (2008) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-008-9155-8 · Cited by 53
Jacques, A. M., Briceno, N., Messer, A. E., Gallon, C. E., Jalilzadeh, S., Garcia, E., Kikonda-Kanda, G., Goddard, J., Harding, S. E., Watkins, H., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn094 · Cited by 43 · cited 1×
“These results are in accord with preliminary measurements on hcTnI using Pro-Q Diamond [8, 45] and reflect a generalised decrease in phosphorylation levels that includes TnT, myosin binding protein-C and myosin light chain-2 [46, 47], presumably associated with increased phosphatase activity [4].”
ResultSelf-citationIsolation and some properties of troponin T kinase from rabbit skeletal muscle
Gusev, N. B., Dobrovol'skiĭ, A. B., & Severin, S. E. (1980) · Biochemical Journal · doi:10.1042/bj1890219 · Cited by 41 · cited 1×
“TnT phosphorylation appears to be constitutive [1] but TnI phosphorylation is controlled dynamically by several kinases and phosphatases [2].”
BackgroundKeane, N. E., Quirk, P. G., Gao, Y. Z., Patchell, V. B., PERRY, S. V., & Levine, B. A. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00329.x · Cited by 38
Microanalysis and Distribution of Cardiac Troponin I Phospho Species in Heart Areas
Ardelt, P., Dorka, P., Jaquet, K., Heilmeyer, L. M. G., Körtke, H., Körfer, R., & Notohamiprodjo, G. (1998) · Biological Chemistry · doi:10.1515/bchm.1998.379.3.341 · Cited by 35
Jacques, A. M., Hoskins, A. C., Kentish, J. C., & Marston, S. B. (2008) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-009-9174-0 · Cited by 34 · cited 15×
“The Pro-Q Diamond-based calculation may be subject to errors due to the variability in sensitivity and potential non-specificity of the Pro-Q Diamond phosphoprotein stain [17, 35] as well as the need for calibration against a separately measured standard.”
ResultInfluentialSelf-citationHeterogeneity in Human Cardiac Troponin I Standards
Bunk, D. M., Dalluge, J. J., & Welch, M. J. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4710 · Cited by 28
Additional PKA phosphorylation sites in human cardiac troponin I
Ward, D. G., Ashton, P. R., Trayer, H. R., & Trayer, I. P. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01871.x · Cited by 27 · cited 5×
“We have uncovered a level of detail previously only measurable by sophisticated MS techniques [16, 30, 31].”
BackgroundMethodResultInfluentialThe use of human cardiac tissue in biophysical research: The risks of translation
Jweied, E. E., de Tombe, P. P., & Buttrick, P. M. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.02.002 · Cited by 27 · cited 1×
“The significance of this observation is that the widespread use of donor heart material as a source of ‘‘normal’’ control tissue has been criticised on the grounds that such tissue may be abnormally highly phosphorylated [7, 36].”
BackgroundSchwoerer, A. P., Neuber, C., Schmechel, A., Melnychenko, I., Mearini, G., Bokník, P., Kirchhefer, U., Schmitz, W. L., Ehmke, H., Eschenhagen, T., et al. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.09.003 · Cited by 26 · cited 1×
“On the other hand, non-specific reduction in phosphorylation is compatible with reports of increased phosphatase activity in failing heart, which may itself be a consequence of enhanced PKC activity [4, 41–44].”
BackgroundTargeting Protein Phosphatase 1 in Heart Failure
Champion, H. C. (2005) · Circulation Research · doi:10.1161/01.res.0000164359.95588.25 · Cited by 20 · cited 1×
“On the other hand, non-specific reduction in phosphorylation is compatible with reports of increased phosphatase activity in failing heart, which may itself be a consequence of enhanced PKC activity [4, 41–44].”
BackgroundPhosphorylation‐specific antibodies for human cardiac troponin‐I
Al‐Hillawi, E., Chilton, D. C., Trayer, I. P., & Cummins, P. L. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2560535.x · Cited by 19 · cited 1×
“Primary antibodies used in this study were: anti-human-cardiac troponin I (hcTnI) clone 14G5 mouse mAb (Abcam plc), 1/2000 dilution; ‘‘anti-Ser23/24-Phos’’ cTnI, rabbit polyclonal antibody (pAb) (Cell Signaling Technology), 1/1000; anti-non-phosphorylated hcTnI mAb clone 22B11 (Abcam plc), 1/2000; ‘‘anti-Thr143-Phos’’…”
MethodEpitope mapping of anti‐troponin I monoclonal antibodies
Filatov, V. L., Katrukha, A., Bereznikova, A. V., Esakova, T. V., Bulargina, T. V., Kolosova, O. V., Severin, E. S., & Gusev, N. B. (1998) · IUBMB Life · doi:10.1080/15216549800203412 · Cited by 18 · cited 1×
“The epitope of this antibody is in the centre of the cTnI sequence, remote from known phosphorylation sites [27].”
BackgroundA monoclonal antibody that distinguishes phospho- and dephosphorylated forms of cardiac troponin-I
CUMMINS, B., RUSSELL, G. J., & Cummins, P. L. (1991) · Biochemical Society Transactions · doi:10.1042/bst019161s · Cited by 10 · cited 1×
“mAb14 has been shown to be specific to cTnI phosphorylated only at Ser23 [29].”
BackgroundCurrent techniques for the study of troponin I phosphorylation in human heart
Gallon, C. E. (2008) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-009-9170-4 · Cited by 9 · cited 1×
“The Pro-Q Diamond-based calculation may be subject to errors due to the variability in sensitivity and potential non-specificity of the Pro-Q Diamond phosphoprotein stain [17, 35] as well as the need for calibration against a separately measured standard.”
BackgroundSelf-citation
Research works printed but not linked: 2
- Jacques A. M., 2007, A comparison between TnT, TnI, MyBP‐C and MLC‐2 phosphorylation in tissue from septal myectomies of hypertrophic obstructive cardiomyopathy patients and donor hearts. Biophysical Society Meeting Abstracts, Biophys. J., S541A
- Messer A. E., 2007, Measurement of troponin phosphatase activities in normal and failing human heart muscle. Biophysical Society Meeting Abstracts, Biophys. J., S630A
Cited by
Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle
Copeland, O., Sadayappan, S., Messer, A. E., Steinen, G. J. M., van der Velden, J., & Marston, S. B. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.09.007 · Cited by 146
“These resultsfit anemergingpattern of reduced phosphorylation of the myofibrillar targets of PKA observed in pathologies that include failing heart, hypertrophic obstructive cardiomyopathy (in the interventricular septum but not necessarily the rest of the heart) and in atrial fibrillation [18,20,21,24,34,35].”
InfluentialSelf-citationHow Do Mutations in Contractile Proteins Cause the Primary Familial Cardiomyopathies?
Marston, S. B. (2011) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-011-9266-2 · Cited by 126
“Troponin I is usually highly phosphorylated in human troponin (approximately 1.1 mol Pi/mol TnI at Ser22 and 23, the PKA sites [ 57 ]), whereas the recombinant proteins previously studied were not phosphorylated.”
BackgroundInfluentialSelf-citationvan Dijk, S. J., Paalberends, E. R., Najafi, A., Michels, M., Sadayappan, S., Carrier, L., Boontje, N. M., Kuster, D. W. D., van Slegtenhorst, M., Dooijes, D., et al. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.963702 · Cited by 124
Ackermann, M. A., Kerr, J. P., King, B., Ward, C. W., & Kontrogianni‐Konstantopoulos, A. (2018) · Scientific Reports · doi:10.1038/srep46969 · Cited by 116
Tucholski, T., Cai, W., Gregorich, Z. R., Bayne, E. F., Mitchell, S. D., McIlwain, S. J., de Lange, W. J., Wrobbel, M., Karp, H., Hite, Z., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006764117 · Cited by 107
“2 A, C, and E) is consistent with previous reports which investigated HCM (59, 61, 62).”
ResultSelf-citation
Metadata
- Authors
- Messer, A. E., Gallon, C. E., McKenna, W. J., Dos Remedios, C. G., & Marston, S. B.
- Affiliations
- Imperial College London (GB)
- University College London (GB)
- Corresponding author
- Messer, Andrew E.
- Venue
- PROTEOMICS – Clinical Applications
- Publisher
- Wiley
- Published
- 2009-12
- Volume
- 3
- Issue
- 12
- Pages
- 1371-1382
- ISSN
- 1862-8346 (ISSN-L)
- 1862-8354
- OpenAlex
- W2020563127
- Cited by
- 61
- References
- 49
- Citations by year
- 2025: 2 · 2022: 4 · 2021: 1 · 2020: 8 · 2019: 1 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 7 · 2014: 6 · 2013: 3 · 2012: 4
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PROTEOMICS - CLINICAL APPLICATIONS (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- British Heart Foundation grant (PG/08/077/25587, RG/02010, PG/06/027/20425)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- cardiac troponin I, protein kinase A, heart failure, hypertrophic obstructive cardiomyopathy, myofibrils
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.